Analgesic effectiveness of wound infiltration with bupivacaine and a mixture of bupivacaine and tramadol for postoperative pain management among participants undergoing elective cesarean section under spinal anesthesia at dilla university general hospital, 2023: a double-blind randomized controlled trial
Phase 4
- Conditions
- Fertility-femaleAnaesthesia
- Registration Number
- PACTR202310525672884
- Lead Sponsor
- Dilla University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
?Pregnant mothers between 18 and 45
?ASA class =II
Exclusion Criteria
?Patients with known allergies to bupivacaine and tramadol
?History of alcohol usage, opiate or other drug abuse
?Pregnant mothers who diagnosed with Chronic pain
?Pregnant mothers with systemic diseases like renal impairment, chronic liver disease, chronic obstructive pulmonary disease, and cardiac disease
?Pregnant mothers with pre-eclampsia, eclampsia
?Spinal anesthesia with adjuvants
?Operation other than the lower uterine segment incision
?Pregnant mothers taking opioids preoperatively
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative total Analgesia consumption in the first 24 hours <br>Time to first analgesic request in minutes<br>Postoperative Pain severity (NRS score (0–10 cm))<br>
- Secondary Outcome Measures
Name Time Method Postoperative nausea and vomiting (3-point scale)